Improving healthcare quality and outcomes in patients with stroke and cardiovascular disease.
With stroke being one of the leading causes of disability and mortality in this country, we use national registries to inform better decision-making for all patients. Our work advocates for the wider adoption of alteplase, antiplatelet therapy in ischemic stroke, secondary stroke prevention, off-label guidelines for those with acute ischemic stroke, and more.
In the News
Urgency in action: How research is revolutionizing stroke care
With stroke being one of the leading causes of disability and mortality in this country, Dr. Xian’s work is paving the way for the wider adoption of alteplase, the only FDA-approved medical therapy for acute ischemic stroke. Significant research is still needed to update stroke guidelines and improve patient outcomes.
View full article on Dr. Xian's work to update stroke guidelines
Program enhances stroke care at nearly 3,000 U.S. hospitals
A study shows a national initiative improved stroke outcomes for millions of patients enhancing quality of care and consistency at more than 2,800 U.S. hospitals including UTSW. Since its inception in 2003, the GWTG-Stroke program has grown to cover over 75% of stroke hospitalizations nationwide, capturing data from 9M+ stroke cases.
View full article and learn about the program